Company Filing History:
2 out of 15 
2 out of 93 
Years Active: 2024-2025
Title: The Innovations of Wonjun Son
Introduction
Wonjun Son is a notable inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of bispecific antibodies for cancer treatment. With a total of 2 patents, his work is paving the way for innovative therapeutic approaches.
Latest Patents
Wonjun Son's latest patents include the "Anti-HER2/anti-4-1BB bispecific antibody and use thereof." This invention provides an anti-4-1BB/anti-HER2 bispecific antibody, along with a pharmaceutical composition and a method for treating and/or preventing cancer using the same. Another significant patent is the "Anti-EGFR/anti-4-1BB bispecific antibody," which offers an anti-4-1BB/anti-EGFR bispecific antibody, along with a pharmaceutical composition and a method for treating and/or preventing cancer.
Career Highlights
Throughout his career, Wonjun Son has worked with prominent companies in the biotechnology sector, including Abl Bio Inc. and Yuhan Corporation. His experience in these organizations has contributed to his expertise in developing innovative cancer therapies.
Collaborations
Some of his notable coworkers include Eun-Jung Lee and Hyejin Chung. Their collaborative efforts have likely enhanced the research and development of his patented technologies.
Conclusion
Wonjun Son's contributions to the field of biotechnology through his innovative patents demonstrate his commitment to advancing cancer treatment. His work continues to inspire future developments in the medical field.